Recent Company News

• 07:35 PM ET Jul 03, 2025
  

  Nxera Pharma to receive $4.8M milestone payment following Centessa's initiation of clinical development of ORX142 (¥857.0000, 0)

• 09:05 AM ET Jun 16, 2025
  

  Centessa Pharmaceuticals announces clearance of IND for ORX142, a novel Orexin Receptor 2 (OX2R) agonist; clinical data in acutely sleep-deprived healthy volunteers planned for this year ($12.38, 0.00)

• 09:00 AM ET Jun 16, 2025
  

  Centessa Pharmaceuticals Announces Clearance of Investigational New Drug Application (IND) for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist; Clinical Data in Acutely Sleep-Deprived Healthy Volunteers Planned for this Year

• 08:58 AM ET Jun 02, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 04:13 PM ET May 28, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 10:18 PM ET Jun 06, 2025
  

  StreetAccount Sector Summary - Healthcare Weekly Recap